These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22427181)

  • 1. Pasteurella multocida and immune cells.
    Kubatzky KF
    Curr Top Microbiol Immunol; 2012; 361():53-72. PubMed ID: 22427181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The key surface components of Pasteurella multocida: capsule and lipopolysaccharide.
    Harper M; Boyce JD; Adler B
    Curr Top Microbiol Immunol; 2012; 361():39-51. PubMed ID: 22373812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signaling cascades of Pasteurella multocida toxin in immune evasion.
    Kubatzky KF; Kloos B; Hildebrand D
    Toxins (Basel); 2013 Sep; 5(9):1664-81. PubMed ID: 24064721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pasteurella multocida pathogenesis: 125 years after Pasteur.
    Harper M; Boyce JD; Adler B
    FEMS Microbiol Lett; 2006 Dec; 265(1):1-10. PubMed ID: 17107417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Pasteurella multocida Toxin on the differentiation of dendritic cells into osteoclasts.
    Chakraborty S; Kloos B; Roetz N; Schmidt S; Eigenbrod T; Kamitani S; Kubatzky KF
    Immunobiology; 2018 Jan; 223(1):142-150. PubMed ID: 29030011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological roles of Pasteurella multocida toxin (PMT) using a PMT mutant strain.
    Kim TJ; Toan NT; Jang EJ; Jung BG; Lee JI; Lee BJ
    J Microbiol; 2007 Aug; 45(4):364-6. PubMed ID: 17846592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pasteurella multocida toxin - lessons learned from a mitogenic toxin.
    Kubatzky KF
    Front Immunol; 2022; 13():1058905. PubMed ID: 36591313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenicity of partial fragments of recombinant Pasteurella multocida toxin.
    Lee J; Woo HJ
    J Microbiol Biotechnol; 2010 Dec; 20(12):1756-63. PubMed ID: 21193834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a toxA gene knock-out mutant of Pasteurella multocida and evaluation of its protective effects.
    Kim TJ; Lee JI; Lee BJ
    J Microbiol; 2006 Jun; 44(3):320-6. PubMed ID: 16820762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pasteurella multocida.(Preface).
    Aktories K; Orth JH; Adler B
    Curr Top Microbiol Immunol; 2012; 361():v. PubMed ID: 23230602
    [No Abstract]   [Full Text] [Related]  

  • 11. Pasteurella multocida toxin prevents osteoblast differentiation by transactivation of the MAP-kinase cascade via the Gα(q/11)--p63RhoGEF--RhoA axis.
    Siegert P; Schmidt G; Papatheodorou P; Wieland T; Aktories K; Orth JH
    PLoS Pathog; 2013; 9(5):e1003385. PubMed ID: 23696743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pasteurella multocida: diseases and pathogenesis.
    Wilkie IW; Harper M; Boyce JD; Adler B
    Curr Top Microbiol Immunol; 2012; 361():1-22. PubMed ID: 22643916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-protection of recombinant Pasteurella multocida toxin proteins against atrophic rhinitis in mice.
    Wu MC; Lo YT; Wu HC; Wang HY; Chu CY
    Res Vet Sci; 2021 Jul; 137():138-143. PubMed ID: 33975192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capsular Polysaccharide Interferes with Biofilm Formation by
    Petruzzi B; Briggs RE; Tatum FM; Swords WE; De Castro C; Molinaro A; Inzana TJ
    mBio; 2017 Nov; 8(6):. PubMed ID: 29162713
    [No Abstract]   [Full Text] [Related]  

  • 15. The Myriad Properties of Pasteurella multocida Lipopolysaccharide.
    Harper M; Boyce JD
    Toxins (Basel); 2017 Aug; 9(8):. PubMed ID: 28825691
    [No Abstract]   [Full Text] [Related]  

  • 16. Protective immunity to Pasteurella multocida heat-labile toxin by intranasal immunization in rabbits.
    Suckow MA; Bowersock TL; Nielsen K; Chrisp CE; Frandsen PL; Janovitz EB
    Lab Anim Sci; 1995 Oct; 45(5):526-32. PubMed ID: 8569151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-silico analysis of Pasteurella multocida to identify common epitopes between fowl, goat and buffalo.
    Ghaffar A; Tariq A
    Gene; 2016 Apr; 580(1):58-66. PubMed ID: 26779825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective potential of an attenuated Pasteurella multocida, which expresses only the N-terminal truncated fragment of P. multocida toxin.
    Seo J; Lee S; Pyo H; Lee J; Kim T
    Can J Vet Res; 2010 Jan; 74(1):25-9. PubMed ID: 20357954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinico-pathology, hematology and biochemistry responses in buffaloes towards Pasteurella multocida type B: 2 immunogen lypopolysaccharide via oral and intravenous routes of infection.
    Chung EL; Abdullah FF; Ibrahim HH; Marza AD; Zamri-Saad M; Haron AW; Lila MA; Norsidin MJ
    Microb Pathog; 2016 Feb; 91():141-54. PubMed ID: 26706347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of plasmid acquisition on potential virulence attributes of Pasteurella multocida.
    Lee MD; Wooley RE
    Avian Dis; 1995; 39(3):451-7. PubMed ID: 8561727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.